Twist Bioscience Corp.

Twist uses a proprietary semiconductor-based manufacturing process that miniaturizes DNA synthesis chemistry onto a silicon chip. This allows high-throughput, parallel synthesis at scales and speeds that traditional column- or plate-based methods cannot match, enabling cost-effective custom gene fragments, oligo pools, and NGS panels.

Twist's synthetic DNA tools are used in medicine (including precision medicine, cancer research, and drug discovery), agriculture (AgBio for trait engineering and crop improvement), and industrial chemicals. The company also serves the infectious disease field and antibody discovery and development.

Yes, Twist's quality management system for its NGS target enrichment panels, reagents, and kits (catalog products) as well as synthetic RNA and DNA controls is ISO 13485:2016 certified. The company is also ISO 27001:2022 certified for information security management.

Twist offers custom gene fragments (including multiplexed gene fragments), oligo pools, NGS target enrichment panels and kits, variant libraries, and antibody discovery solutions. They also provide synthetic RNA and DNA standards for assay development.

Twist serves both academic researchers and commercial entities. Its website offers a special 30% discount for new customers on initial multiplexed gene fragment orders, and the company provides customer support and science teams to help customize services to specific research needs.

Twist's headquarters is in South San Francisco, CA with additional offices in Tel Aviv (Israel), Carlsbad (CA), Boston (MA), Portland (OR), Singapore, Guangzhou (China), and South Korea. There is also a European sales office.

Twist maintains a Code of Business Conduct & Ethics aligned with principles of service, grit, impact, and trust. It consults its legal department on all written and spoken materials and public communications to ensure compliance with laws and regulations, and it strives to deal fairly with customers, partners, competitors, and the public.